277 results
424B7
EXAS
Exact Sciences Corp.
8 May 24
Prospectus with selling stockholder info
5:08pm
not offer our Cologuard test outside of the U.S.
Pipeline Research and Development
Our research and development efforts are focused on developing new … , and other sample types. In September 2020, Mayo agreed to make available certain personnel to provide us research and development assistance through
8-K
EX-99.1
EXAS
Exact Sciences Corp.
8 May 24
Exact Sciences Announces First-Quarter 2024 Results
4:08pm
(exclusive of amortization of acquired intangible assets)
Research and development
Sales and marketing
General and administrative
Amortization of acquired
8-K
EX-99.1
vzaf 7p4lf
21 Feb 24
Exact Sciences Announces Fourth Quarter 2023 Results
4:40pm
8-K
EX-99
ybu67
1 Nov 23
Exact Sciences Announces Third-Quarter 2023 Results Reports record revenue, delivers more than a million test results, raises full-year guidance
4:09pm
8-K
EX-99
uzklepadt 2g
1 Aug 23
Exact Sciences Announces Second-Quarter 2023 Results Reports record results, generates positive free cash flow, raises full-year guidance
4:08pm
S-3ASR
4v1c6 6uvn6
25 May 23
Automatic shelf registration
4:01pm
8-K
EX-99
97dqa40mmcnp
9 May 23
Exact Sciences Announces First Quarter 2023 Results Reports record results, raises full-year guidance, accelerates path to positive free cash flow
4:09pm
8-K
EX-99
ccxz923ade y1oajl
3 Nov 22
Exact Sciences Announces Third Quarter 2022 Results Reports Record Revenue, Raises Full-Year Guidance, Accelerates Path to Profitability
4:09pm
8-K
EX-99
rhaes
2 Aug 22
Exact Sciences Announces Second Quarter 2022 Results
4:12pm
424B7
t4xxxs32z0pojqfd
2 May 22
Prospectus with selling stockholder info
4:01pm